Showing results (211-220 of 337) with videos related to

Sort By:
Pageof 34
Hypertension (Dallas, Tex. : 1979)|October 7, 2009
Angiotensin receptor blocker prevented beta-amyloid-induced cognitive impairment associated with recovery of neurovascular couplingShuko Takeda, Naoyuki Sato, Daisuke Takeuchi, et al.
Hypertension (Dallas, Tex. : 1979)|July 9, 2004
Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial diseaseRyuichi Morishita, Motokuni Aoki, Naotaka Hashiya, et al.
Endocrine|March 11, 2005
Klotho protein activates the PKC pathway in the kidney and testis and suppresses 25-hydroxyvitamin D3 1alpha-hydroxylase gene expressionMichio Imai, Kazuhiko Ishikawa, Naomichi Matsukawa, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 2004
Homocysteine enhances endothelial apoptosis via upregulation of Fas-mediated pathwaysToshimitsu Suhara, Keisuke Fukuo, Osamu Yasuda, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 2, 2004
CYP11B2 polymorphisms and home blood pressure in a population-based cohort in Japanese: the Ohasama studyMitsunobu Matsubara, Tomomi Sato, Takuya Nishimura, et al.
Circulation|September 24, 2004
Periostin as a novel factor responsible for ventricular dilationNaruto Katsuragi, Ryuichi Morishita, Noriko Nakamura, et al.
Circulation|March 13, 2002
Local delivery of plasmid DNA into rat carotid artery using ultrasoundYoshiaki Taniyama, Katsuro Tachibana, Kazuya Hiraoka, et al.
Journal of Human Genetics|October 17, 2009
Evaluation of genetic loci influencing adult height in the Japanese populationFumihiko Takeuchi, Toru Nabika, Masato Isono, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 26, 2014
Combination therapy of hypertension in the elderly: a subgroup analysis of the Combination of OLMesartan and a calcium channel blocker or diuretic in Japanese elderly hypertensive patients trialToshio Ogihara, Takao Saruta, Hiromi Rakugi, et al.
Diabetology International|January 4, 2019
Effects of ipragliflozin, a selective sodium-glucose co-transporter 2 inhibitor, on blood pressure in Japanese patients with type 2 diabetes mellitus: a pooled analysis of six randomized, placebo-controlled clinical trialsAtsunori Kashiwagi, Satoshi Yoshida, Kosei Kawamuki, et al.
Pageof 34